Dyne Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Dyne Therapeutics | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Updated December 28, 2025
Public ProfileLinkedInLinkedIn Profile

Dyne Therapeutics is a clinical-stage biotechnology company based in Waltham, Massachusetts, dedicated to developing targeted therapeutics for serious neuromuscular diseases.

Employees75
Revenue$3.9B
Market Cap2.9B

Industry & Market

Primary Industry
research
Location
Waltham, Massachusetts, United States
Public Trading
NASDAQ: DYN

Funding Information

Annual Revenue
$3,870,000,000
Publicly traded company

Headcount Distribution

Total Employees
75
Departments
19

By Department

Department Breakdown

Operations
Information Technology
Human Resources
Business Development
Education
Accounting
Others

Keywords & Focus Areas

biotechnology: pharmaceutical preparationshealth carebiotechnology researchdrug developmentmolecular conjugatesmolecular targetingbiotechnologyfshd dux4 targetingenvironmental sustainabilityclinical trialsenzyme replacement therapyservicestargeted therapiesmuscle deliverygene therapy deliverytherapeutic conjugatespersonalized medicineantisense conjugatesclinical-stage biotechre-dosing potential+10 more
30 total keywords

Overview

Dyne Therapeutics is a clinical-stage biotechnology company based in Waltham, Massachusetts, dedicated to developing targeted therapeutics for serious neuromuscular diseases. Founded in 2017, the company utilizes its proprietary FORCE™ platform to deliver disease-modifying oligonucleotide therapies directly to muscle tissue and the central nervous system, with the goal of halting or reversing disease progression.

The company's pipeline includes investigational therapies for conditions such as Myotonic Dystrophy Type 1, Duchenne Muscular Dystrophy, and Facioscapulohumeral Muscular Dystrophy, among others. Its FORCE™ platform enhances the delivery of therapeutic oligonucleotides by conjugating them with antibodies, improving their efficiency and specificity to muscle cells. Dyne Therapeutics is committed to advancing innovative treatments through rigorous clinical trials and collaborations, working closely with regulatory agencies to bring its therapies to patients in need.

Key Metrics

Total Employees
XXXX
Total number of employees
Engineering
XX
Number of employees in the engineering department
Sales Team
$XX
Number of employees in the sales department
Marketing
XX
Number of employees in the marketing department
Founded
XXXX
Year the company was founded
Revenue
$XXX,XXX,XXX
Total revenue of the company
Total Funding
$XXX M
Total funding of the company
Market Cap
$XXX,XXX
Market cap of the company

Get Complete Company Metrics

Dive deeper into employee structure, funding, revenue, and key performance indicators all in one place.

Start For Free

Contact

Company
Dyne Therapeutics
Headquarters
1560 Trapelo Rd, Waltham, Massachusetts 02451, US
Founded
2017
Industry
research

Technology Stack

Analytics & Tracking

Google AnalyticsGoogle Tag Manager

Social & Marketing

Not found

Database & Backend

Not found

Cloud & Infrastructure

Google Cloud Hosting

Productivity

Not found

Compare similar companies to Dyne Therapeutics

Compare insights from companies similar to Dyne Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company NameRevenueNo. of EmployeesTypeFundingFounded InTop Executive
xxxxxxx
$13503103Private-8511
xxxxxxxxx
xxx
$8543530Private-5677
xxxx
xxxxxxxxx
$88926107Private-9136
xxxxx
xxxxxxxx
$9666327Private-7247
xxxxxxxxxx
xxx
$8850233Private-815
xxxxxxxxx

Discover Similar Companies Instantly

Explore detailed insights and analysis on companies related to your search.

Start For Free

Turn this profile into a pipeline

Find decision makers, more insights and contact information about this company on Bitscale

Start For Free

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

Start for Free